Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria Céu Trindade"'
Autor:
Vítor Borges, Joana Isidro, Mário Cunha, Daniela Cochicho, Luís Martins, Luís Banha, Margarida Figueiredo, Leonor Rebelo, Maria Céu Trindade, Sílvia Duarte, Luís Vieira, Maria João Alves, Inês Costa, Raquel Guiomar, Madalena Santos, Rita Cortê-Real, André Dias, Diana Póvoas, João Cabo, Carlos Figueiredo, Maria José Manata, Fernando Maltez, Maria Gomes da Silva, João Paulo Gomes
Publikováno v:
mSphere, Vol 6, Iss 4 (2021)
Tracking the within-patient evolution of SARS-CoV-2 is key to understanding how this pandemic virus shapes its genome toward immune evasion and survival. In the present study, by monitoring a long-term COVID-19 immunocompromised patient, we observed
Externí odkaz:
https://doaj.org/article/45f69a8b49154c4499c10add6c4cafff
Autor:
Diana Póvoas, Maria Céu Trindade, Carlos Figueiredo, Luís Banha, Fernando Maltez, Mário Cunha, João Paulo Gomes, Luís Vieira, Maria João Alves, João Cabo, Vítor Borges, Maria José Manata, Maria Gomes da Silva, Luís Martins, Rita Côrte-Real, Joana Isidro, Leonor Rebelo, Daniela Cochicho, Raquel Guiomar, Andre Roncon Dias, Inês Costa, Margarida Figueiredo, Sílvia Duarte, M Santos
Publikováno v:
mSphere
mSphere, Vol 6, Iss 4 (2021)
mSphere, Vol 6, Iss 4 (2021)
Recent studies have shown that persistent SARS-CoV-2 infections in immunocompromised patients can trigger the accumulation of an unusual high number of mutations with potential relevance at both biological and epidemiological levels. Here, we report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::193bf6c280f115cb8915cf5b69bf341a
https://hdl.handle.net/10400.18/8052
https://hdl.handle.net/10400.18/8052
Autor:
Catalina Gómez, José Cabeçadas, Maria Céu Trindade, Maria Gomes da Silva, Rita Gavancha, Gonçalo Esteves, Inês Barbosa, Susana Carvalho, Ivan Dlouhy, Ana Filipa Moita, Inês Coelho, Paula Gameiro
Publikováno v:
Blood. 134:5287-5287
Introduction: Peripheral T-cell lymphomas (PTCL) are a heterogeneous group of mature T-cell neoplasms with aggressive behavior and dismal outcomes. Anthracycline-based chemotherapy is commonly used upfront; hematopoietic stem-cell transplantation (HS
Autor:
Herlander Marques, Maria Céu Trindade, Ricardo J. S. Costa, Jorge Espírito Santo, Emília Magalhães, Ana Marques Pereira, Rute Vieira, Adriana Teixeira
Publikováno v:
Blood. 112:5006-5006
The first line treatment regimen differs according to the type of lymphoma. ABVD for Hodgkin’s Lymphomas (HL) and CHOP or R-CHOP for non-Hodgkin’s Lymphomas (NHL) are the most worldwide used treatments. There is good evidence that reduction in re